PATENT CLAIM ANALYSIS

Application Number: 16188905
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "553000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing small dense LDL (“sdLDL”) oxidation in a subject, the method comprising administering to the subject a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 19):
The method of  claim 18  further comprising measuring membrane cholesterol domain formation in the subject after administering to the subject the pharmaceutical composition.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15312113', '15415667', '14729615', '14704329', '14175602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5779444643926837
- 35 USC 102 Novelty (BERT): 0.5459553990696302
- Combined Prediction Score: 0.5747455578603783
- Mean Citation Score: 284.884248
- Max Citation Score: 423.68152
- Similarity Product: 235.0627388342524

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test